G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial

Abstrakt

Academic, open label, randomized trial: G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome. GA trial is registered under EudraCT#: 2013-001639-38.

Klíčová slova

• conventional care regimens
• colony-stimulating factors
• acute myeloid-leukemia
• chemotherapy
• survival